PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 20 filers reported holding PROQR THRAPEUTICS N V in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,919,000 | -0.6% | 383,821 | -2.5% | 0.00% | 0.0% |
| Q4 2016 | $1,930,000 | -28.0% | 393,860 | -2.0% | 0.00% | 0.0% |
| Q3 2016 | $2,682,000 | +34.5% | 402,096 | -2.4% | 0.00% | 0.0% |
| Q2 2016 | $1,994,000 | -4.5% | 411,983 | -3.8% | 0.00% | 0.0% |
| Q1 2016 | $2,089,000 | -68.7% | 428,161 | -44.3% | 0.00% | -66.7% |
| Q4 2015 | $6,678,000 | -70.3% | 769,337 | -50.2% | 0.01% | -40.0% |
| Q3 2015 | $22,490,000 | +47.3% | 1,543,624 | +68.6% | 0.01% | -23.1% |
| Q2 2015 | $15,263,000 | -37.4% | 915,576 | -17.8% | 0.01% | -35.0% |
| Q1 2015 | $24,365,000 | +50.6% | 1,113,568 | +49.2% | 0.02% | +42.9% |
| Q4 2014 | $16,177,000 | +34.7% | 746,525 | +6.8% | 0.01% | +27.3% |
| Q3 2014 | $12,013,000 | – | 698,838 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,237,400 | $5,197,000 | 1.55% |
| Prosight Management, LP | 255,000 | $1,071,000 | 0.50% |
| RTW INVESTMENTS, LP | 5,009,768 | $21,041,000 | 0.35% |
| Kerrisdale Advisers, LLC | 453,182 | $1,903,000 | 0.15% |
| Artal Group S.A. | 1,196,218 | $5,024,000 | 0.11% |
| COWEN AND COMPANY, LLC | 285,696 | $1,200,000 | 0.11% |
| Golden Green, Inc. | 16,999 | $71,000 | 0.07% |
| APOGEM CAPITAL LLC | 15,855 | $67,000 | 0.04% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $19,110,000 | 0.04% |
| ALTRINSIC GLOBAL ADVISORS LLC | 241,360 | $1,014,000 | 0.03% |